Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accredited, affirmative, age, airplane, Alabama, Aon, ASUNo, Athenix, Atlantic, attached, attorney, auditor, azacitidine, Bachelor, Berkeley, billed, biology, biotech, blast, bloodstream, boosting, Branch, British, broker, CA, Campaign, Campbell, captured, career, Carolina, Cellectar, Cerecor, certified, Chair, Chairperson, Chapel, charter, Chelsea, chemotherapeutic, Cincinnati, circumstance, clear, closer, COBRA, College, Columbia, comfort, Concordia, conflict, contendere, conviction, copy, count, coupled, CRC, crime, Cultivation, cumbersome, cycle, database, decitabine, Delcath, delegated, description, disability, disinterested, dispose, disposition, diversify, Division, double, droxidopa, eighteen, ensuing, Environmental, Essex, expert, family, felony, fifty, fight, Gray, guest, headcount, hedge, Hewitt, Hill, Hoechst, idarubucin, immuno, Incumbent, infiltrating, injectable, instructed, internist, intra, joining, kill, KineMed, Likewise, London, lymphocyte, malfeasance, malignant, Marion, Master, merger, Microcirculation, moral, MTD, Narrative, Neurobiological, neurogenerative, nolo, nominated, nominating, nomination, NTI, NY, ofRule, older, omission, Osteologix, Owner, parent, Parkinson, partner, paused, PCAOB, peer, Pharma, pharmacology, philosophy, plea, Ponton, posted, Poulenc, prioritize, properly, provisional, Radford, reassessed, recipient, RegulationSection, reinstate, reinstatement, residence, resident, resignation, resort, retired, retirement, ReynoldsMr, rheumatologist, Rhone, riskiest, role, Rorer, roundtrip, Roussell, RPR, salesperson, Saskatchewan, school, segregation, senior, solicit, Southampton, sport, statute, step, stimulate, stimulation, stream, suitable, Taekwondo, tangible, text, threatened, ticket, title, Topic, traditionally, turpitude, unique, USA, vaccine, vehicle, venture, Vice, Virolab, virtually, Waterloo, website, Whitman, widespread, workforce, Wyrick, Xenova
Removed:
abdomen, Acceleration, adding, additive, addressed, administer, American, answer, ASH, ATC, AURELIA, automatically, avastin, biologic, block, caption, carboplatin, carcinoma, choice, Christie, CI, circulating, cisplatin, claim, closely, clot, combretastatin, commencing, comparing, competitor, complying, constantly, coordinated, Coordination, CTEP, deducting, degradation, demonstrating, designing, detection, determining, disorder, dispersed, documented, downstream, doxorubicin, East, enable, enhanced, enzyme, epithelial, escalation, ethically, Europe, exceed, expectation, expended, expertise, fallopian, fatal, fever, Florida, fosbretabulin, Foundation, fungal, gathered, gemcitabine, Genentech, geographically, GlaxoSmithKline, GOG, gynecologic, hazard, healthy, Hertfordshire, impacted, impaired, inflammation, inhibit, inhibiting, inhibitor, Institute, intent, interval, investor, largely, liposomal, liver, Lymphoma, Manchester, mandatory, Marsden, MDS, measurable, MediciNova, monoclonal, myelodysplastic, NCI, NHS, nonprofit, NRG, occurring, offering, ORR, OS, paclitaxel, parasitic, pegylated, peritoneal, PFS, physician, posed, potent, preserving, profile, progression, proper, Proposal, prosecute, quantified, randomized, RCC, recovered, recruitment, recurrence, regimen, released, renal, resistant, responsive, rest, robust, Royal, sarcoma, secured, selectively, Society, soft, SPA, sponsored, sponsorship, STS, subgroup, submitting, supposed, tissue, topotecan, tromethamine, tube, unchanged, understood, upcoming, vital, votrient, women
Filing tables
Filing exhibits
OTLC similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1. | Registration Statement (FormS-8 Nos.333-126636,333-177628,333-181810 and333-190409) pertaining to the Mateon Therapeutics, Inc. 2005 Stock Plan, as amended, |
2. | Registration Statement (FormS-8No. 333-159585) pertaining to the Mateon Therapeutics, Inc. 2005 Stock Plan and the Mateon Therapeutics, Inc. 2009 Employee Stock Purchase Plan, and |
3. | Registration Statement (FormS-8No. 333-204500) pertaining to the Mateon Therapeutics, Inc. 2015 Equity Incentive Plan |
of our report dated April 17, 2018 (which report expresses an unqualified opinion and includes an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern), with respect to the financial statements of Mateon Therapeutics, Inc., included in this Annual Report (Form10-K) for the year ended December 31, 2017.
/s/ OUM & CO. LLP
San Francisco, California
April 17, 2018